J. Pérez-Simón

J. S. San Miguel, J. Pérez-Simón, T. Caballero-Velázquez, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Beclometasone dipropionate: a topically active corticosteroid for the treatment of gastrointestinal graft-versus-host disease

F. Sánchez-Guijo, J. Pérez-Simón, M. Díez-Campelo, 2008, Expert opinion on investigational drugs.

Prognostic factors of chronic graft-versus-host disease following allogeneic peripheral blood stem cell transplantation: the national institutes health scale plus the type of onset can predict survival rates and the duration of immunosuppressive therapy.

E. Colado, F. Sánchez-Guijo, J. S. San Miguel, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting.

F. J. Gonzalez, E. Ballestar, B. Blanco, 2010, Blood.

PTPN13 and β-Catenin Regulate the Quiescence of Hematopoietic Stem Cells and Their Interaction with the Bone Marrow Niche

L. San-Segundo, F. Sánchez-Guijo, J. Pérez-Simón, 2015, Stem cell reports.

International Myeloma Working Group consensus statement regarding the current status of allogeneic stem-cell transplantation for multiple myeloma.

H. Einsele, N. Kröger, G. Gahrton, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Total body irradiation + fludarabine compared to busulfan + fludarabine as “reduced-toxicity conditioning” for patients with acute myeloid leukemia treated with allogeneic hematopoietic cell transplantation in first complete remission: a study by the Acute Leukemia Working Party of the EBMT

A. Ganser, J. Johansson, R. Fanin, 2020, Bone Marrow Transplantation.

CD4+ and CD8+ T-cell responses in bone marrow to fatty acids in high-fat diets.

M. A. Rosillo, J. Pérez-Simón, M. Muñiz, 2022, The Journal of nutritional biochemistry.

Effect of Vitamin D on Graft-versus-Host Disease

J. Pérez-Simón, A. Rodríguez-Gil, Estrella Carrillo‐Cruz, 2022, Biomedicines.

Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning.

J. Briones, J. Queraltó, J. Sierra, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Selection of Tumor-Specific Cytotoxic T Lymphocytes in Acute Myeloid Leukemia Patients Through the Identification of T-Cells Capable to Establish Stable Interactions With the Leukemic Cells: “Doublet Technology”

J. Pérez-Simón, L. Sánchez-Abarca, T. Caballero-Velázquez, 2018, Front. Immunol..

Differential Engraftment of Parental A20 PD-L1 WT and PD-L1 KO Leukemia Cells in Semiallogeneic Recipients in the Context of PD-L1/PD-1 Interaction and NK Cell-Mediated Hybrid Resistance

J. Rodriguez-Barbosa, J. Pérez-Simón, M. Del Río, 2022, Frontiers in Immunology.

Critical role of PD-L1 expression on non-tumor cells rather than on tumor cells for effective anti-PD-L1 immunotherapy in a transplantable mouse hematopoietic tumor model

J. Rodriguez-Barbosa, J. Pérez-Simón, M. Del Río, 2020, Cancer Immunology, Immunotherapy.

Allogeneic stem cell transplantation as a curative option in relapse/refractory diffuse large B cell lymphoma: Spanish multicenter GETH/GELTAMO study

G. Gutiérrez-García, C. Solano, J. Pérez-Simón, 2021, Bone Marrow Transplantation.

Frequency, characteristics, and outcome of PTLD after allo‐SCT: A multicenter study from the Spanish group of blood and marrow transplantation (GETH)

C. Solano, J. Pérez-Simón, R. Martino, 2019, European journal of haematology.

Role of 18F‐FDG‐PET/CT in the management of marginal zone B cell lymphoma

J. Pérez-Simón, V. Marín-Oyaga, I. Borrego‐Dorado, 2015, Hematological oncology.

Fludarabine, cyclophosphamide and rituximab as first‐line treatment in patients with newly diagnosed follicular lymphoma

J. Pérez-Simón, Estrella Carrillo‐Cruz, E. Ríos-Herranz, 2014, European journal of haematology.

Prognostic impact of pre-transplantation computed tomography and 67gallium scanning in chemosensitive diffuse large B cell lymphoma patients undergoing hematopoietic stem-cell transplantation

J. Pérez-Simón, I. G. Escobar, P. Alonso, 2008, Annals of nuclear medicine.

A Conditional Mouse Mutant in the Tumor Suppressor SdhD Gene Unveils a Link between p21WAF1/Cip1 Induction and Mitochondrial Dysfunction

J. López-Barneo, J. Pérez-Simón, J. I. Piruat, 2014, PloS one.

Panobinostat as part of induction and maintenance for elderly patients with newly diagnosed acute myeloid leukemia: phase Ib/II panobidara study

Marcos González, A. Oriol, M. Sanz, 2015, Haematologica.

Genotoxicity of tetrahydrofolic acid to hematopoietic stem and progenitor cells

J. Pérez-Simón, C. García-Calderón, I. V. Rosado, 2018, Cell Death & Differentiation.

Clinical impact of human Jurkat T-cell-line-derived antithymocyte globulin in multiple myeloma patients undergoing allogeneic stem cell transplantation

N. Kröger, D. Atanackovic, A. Zander, 2008, Haematologica.

PD-1 genotype of the donor is associated with acute graft-versus-host disease after HLA-identical sibling donor stem cell transplantation

Marcos González, I. Buño, C. Solano, 2018, Annals of Hematology.

Donor CTLA-4 Genotype Modulates the Immune Response to Minor Histocompatibility Antigen Mismatches.

Marcos González, I. Buño, S. Brunet, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bortezomib induces selective depletion of alloreactive T lymphocytes and decreases the production of Th1 cytokines.

A. Pandiella, B. Blanco, Xonia Carvajal-Vergara, 2006, Blood.

Long-term immune recovery of patients undergoing allogeneic stem cell transplantation: a comparison with their respective sibling donors.

A. Órfão, F. Sánchez-Guijo, J. S. San Miguel, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Short-term endothelial progenitor cell colonies are composed of monocytes and do not acquire endothelial markers.

B. Blanco, F. Sánchez-Guijo, J. S. San Miguel, 2007, Cytotherapy.

Proportion of S-phase tumor cells measured by flow cytometry is an independent prognostic factor in meningioma tumors.

A. Órfão, J. Pérez-Simón, J. Ciudad, 1999, Cytometry.

A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma.

J. S. San Miguel, J. Pérez-Simón, J. Bladé, 2008, Blood.

Correlation of rhodamine 123 efflux by neoplastic plasma cells with clinical and biological characteristics of multiple myeloma.

A. Órfão, J. S. San Miguel, N. Gutiérrez, 1999, Cytometry.

PTPN13 regulates cellular signalling and β-catenin function during megakaryocytic differentiation.

F. Antequera, J. Pérez-Simón, L. Quintales, 2014, Biochimica et biophysica acta.

The Dynamics of the Human Leukocyte Antigen Head Domain Modulates Its Recognition by the T-Cell Receptor

J. Pérez-Simón, A. Díaz-Quintana, I. Díaz-Moreno, 2016, PloS one.

Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation.

J. Miguel, S. Brunet, J. Pérez-Simón, 2003, Blood.

Vitamin D Modifies the Incidence of Graft-versus-Host Disease after Allogeneic Stem Cell Transplantation Depending on the Vitamin D Receptor (VDR) Polymorphisms

F. Sánchez-Guijo, J. Pérez-Simón, M. Alcoceba, 2019, Clinical Cancer Research.

Immunomodulatory Effect of Vitamin D after Allogeneic Stem Cell Transplantation: Results of a Prospective Multicenter Clinical Trial

F. Sánchez-Guijo, A. Carrillo-Vico, J. Pérez-Simón, 2016, Clinical Cancer Research.

Polyphenolic extract (PE) from olive oil exerts a potent immunomodulatory effect and prevents graft-versus-host disease in a mouse model.

M. Sánchez-Hidalgo, C. Alarcón-de-la-Lastra, M. Barbado, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

and decreases the production of Th1 cytokines Bortezomib induces selective depletion of alloreactive T lymphocytes

J. Miguel, A. Pandiella, B. Blanco, 2012 .

Treatment with bortezomib of human CD4+ T cells preserves natural regulatory T cells and allows the emergence of a distinct suppressor T-cell population

B. Blanco, F. Sánchez-Guijo, P. Hernández-Campo, 2009, Haematologica.

Prognostic factors for donor lymphocyte infusions following non-myeloablative allogeneic stem cell transplantation in multiple myeloma

H. Goldschmidt, J. Miguel, N. Kröger, 2006, Bone Marrow Transplantation.

Long-term survival of 1338 MM patients treated with tandem autologous vs. autologous-allogeneic transplantation

Riddhi A Modi, A. Krishnan, S. Iacobelli, 2020, Bone Marrow Transplantation.

Haploidentical transplantation and posttransplant cyclophosphamide for treating aplastic anemia patients: a report from the EBMT Severe Aplastic Anemia Working Party

A. Ganser, N. Kröger, N. Russell, 2019, Bone Marrow Transplantation.

Graft-versus-host disease prophylaxis: Pathophysiology-based review on current approaches and future directions.

J. Pérez-Simón, R. Zeiser, N. Martínez-Cibrián, 2020, Blood reviews.

Prognostic impact of pretransplantation computed tomography and gallium scans in patients with Hodgkin lymphoma with poor prognosis undergoing hematopoietic stem cell transplantation.

J. S. San Miguel, J. Pérez-Simón, P. Tamayo, 2006, Clinical lymphoma & myeloma.

Vitamin D: Effect on Haematopoiesis and Immune System and Clinical Applications

J. Pérez-Simón, Estrella Carrillo‐Cruz, M. Medrano, 2018, International journal of molecular sciences.

Optimisation of empirical antimicrobial therapy in patients with haematological malignancies and febrile neutropenia (How Long study): an open-label, randomised, controlled phase 4 trial.

J. Pérez-Simón, J. Cisneros, M. Aguilar‐Guisado, 2017, The Lancet. Haematology.

SF3B1, RUNX1 and TP53 Mutations Significantly Impact the Outcome of Patients With Lower-Risk Myelodysplastic Syndrome.

J. Pérez-Simón, I. Espigado, J. Falantes, 2022, Clinical lymphoma, myeloma & leukemia.

B- and T-Lymphocyte Attenuator Targeting Protects Against the Acute Phase of Graft Versus Host Reaction by Inhibiting Donor Anti-Host Cytotoxicity

J. Rodriguez-Barbosa, J. Pérez-Simón, M. Del Río, 2011, Transplantation.

The effect of mesenchymal stem cells on the viability, proliferation and differentiation of B-lymphocytes

B. Blanco, E. Ocio, F. Sánchez-Guijo, 2008, Haematologica.

Kinetics of recovery of dendritic cell subsets after reduced-intensity conditioning allogeneic stem cell transplantation and clinical outcome

E. Montserrat, M. Aymerich, J. Sierra, 2007, Haematologica.

Modulation of cytotoxic responses by targeting CD160 prolongs skin graft survival across major histocompatibility class I barrier

J. Rodriguez-Barbosa, J. Pérez-Simón, M. Del Río, 2017, Translational research : the journal of laboratory and clinical medicine.

Impact of hyperferritinemia on the outcome of reduced-intensity conditioning allogeneic hematopoietic cell transplantation for lymphoid malignancies.

J. Sierra, J. Pérez-Simón, R. Martino, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Pretransplantation liver function impacts on the outcome of allogeneic hematopoietic stem cell transplantation: a study of 455 patients.

J. Sierra, J. Pérez-Simón, R. Martino, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival.

J. Sierra, J. Besalduch, J. Pérez-Simón, 2008, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Chronic but not acute graft‐versus‐host disease improves outcome in multiple myeloma patients after non‐myeloablative allogeneic transplantation

J. S. San Miguel, J. Pérez-Simón, R. Martino, 2003, British journal of haematology.

Graft vs. Host Disease and Graft vs. Myeloma Effect after Non-myeloablative Allogeneic Transplantation

J. S. San Miguel, J. S. San Miguel, J. Pérez-Simón, 2004, Leukemia & lymphoma.

The composition of leukapheresis products impacts on the hematopoietic recovery after autologous transplantation independently of the mobilization regimen

F. Prósper, J. Garcia-conde, J. Miguel, 2002, Transfusion.

In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.

B. Blanco, J. S. San Miguel, M. D. del Cañizo, 2007, Transfusion and apheresis science : official journal of the World Apheresis Association : official journal of the European Society for Haemapheresis.

Anti-common γ-chain antibody: one for all in GVHD.

J. Pérez-Simón, 2015, Blood.

Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma.

J. S. San Miguel, M. D. del Cañizo, J. Pérez-Simón, 2005, Haematologica.

Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura.

B. Blanco, J. S. San Miguel, J. Pérez-Simón, 2009, Cytotherapy.

Results of autologous transplantation in lymphoma are not improved by increasing the dose of etoposide in the BEAM regimen: a single-centre sequential-cohort study

J. Pérez-Simón, M. Mateos, M. Caballero, 2004, Bone Marrow Transplantation.

Performance of prognostic scoring systems in elderly patients with acute myeloid leukaemia on intensive chemotherapy: A PETHEMA registry study.

M. Tormo, J. Pérez-Simón, D. Martínez-Cuadrón, 2020, Leukemia research.

Patterns of infection in patients with myelodysplastic syndromes and acute myeloid leukemia receiving azacitidine as salvage therapy. Implications for primary antifungal prophylaxis.

J. Pérez-Simón, M. Aguilar‐Guisado, C. Calderón, 2014, Clinical lymphoma, myeloma & leukemia.

Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study

J. Sierra, J. Pérez-Simón, T. Caballero-Velázquez, 2019, Bone Marrow Transplantation.

Limbus damage in ocular graft-versus-host disease.

B. Blanco, T. Flores, S. Carrancio, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Minimal residual disease monitoring after allogeneic transplantation may help to individualize post‐transplant therapeutic strategies in acute myeloid malignancies

J. S. San Miguel, J. Pérez-Simón, M. Alcoceba, 2009, American journal of hematology.

Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes.

J. Sierra, C. Solano, J. S. San Miguel, 2002, Blood.

Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial

B. Leber, M. Heuser, J. Cortes, 2019, Annals of Hematology.

[Myelodysplastic syndromes and acute myeloid leukemia with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) abnormality].

J. Pérez-Simón, J. Falantes, R. Bernal, 2015, Medicina clinica.

Incidence of chromosome numerical changes in multiple myeloma: fluorescence in situ hybridization analysis using 15 chromosome-specific probes.

A. Órfão, F. S. Miguel, J. S. San Miguel, 1996, The American journal of pathology.

An Active Isodicentric X Chromosome in a Case of Refractory Anaemia with Ring Sideroblasts Associated with Marked Thrombocytosis

J. Pérez-Simón, Javier Sánchez, J. Falantes, 2014, Case reports in genetics.

Improvement over the years of long-term survival in high-risk lymphoma patients treated with hematopoietic stem cell transplantation as consolidation or salvage therapy.

J. Pérez-Simón, I. Espigado, R. Parody, 2013, Transplantation proceedings.

KIT D816V− chronic myelomonocytic leukemia progressing to KIT D816V+ associated to mast cell leukemia responding to allogeneic hematopoietic cell transplantation

J. Pérez-Simón, T. Caballero-Velázquez, J. Borrero, 2018, Annals of Hematology.

The novel combination of sirolimus and bortezomib prevents graft-versus-host disease but maintains the graft-versus-leukemia effect after allogeneic transplantation

B. Blanco, S. Carrancio, S. Gutierrez-Cosío, 2012, Haematologica.

Therapeutic implications of NK cell regulation of allogeneic CD8 T cell-mediated immune responses stimulated through the direct pathway of antigen presentation in transplantation

P. Schneider, J. Pérez-Simón, M. Del Río, 2018, mAbs.

Alemtuzumab as treatment of steroid-refractory acute graft-versus-host disease: results of a phase II study.

C. Solano, J. Pérez-Simón, C. Martínez, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association Between The Hematopoietic Cell Transplantation-Specific Comorbidity Index (CIn) And Non-Relapse Mortality (NRM) After Reduced Intensity Conditioning (RIC) Allogeneic Stem Cell Transplantation (Allo-SCT) For Acute Myeloid Leukemia (AML) In First Complete Remission (CR1)

N. Kröger, M. Labopin, D. Blaise, 2010 .

Emerging BCR/ABL1 Mutations Under Treatment with Tyrosine Kinase Inhibitors in Paediatric Acute Lymphoblastic Leukaemia

J. Pérez-Simón, Á. Molinos-Quintana, R. García-Lozano, 2015, Acta Haematologica.

Tacrolimus plus sirolimus with or without ATG as GVHD prophylaxis in HLA-mismatched unrelated donor allogeneic stem cell transplantation

J. Perkins, C. Solano, J. Pidala, 2017, Bone Marrow Transplantation.

Sequential third-party mesenchymal stromal cell therapy for refractory acute graft-versus-host disease.

E. Andreu, F. Prósper, F. Sánchez-Guijo, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Delayed administration of ixazomib modifies the immune response and prevents chronic graft-versus-host disease

M. Barbado, J. Pérez-Simón, T. Caballero-Velázquez, 2021, Bone Marrow Transplantation.

Posttransplant hematopoiesis in patients undergoing sibling allogeneic stem cell transplantation reflects that of their respective donors although with a lower functional capability.

A. Órfão, F. Sánchez-Guijo, J. S. San Miguel, 2005, Experimental hematology.

p22phox-dependent NADPH oxidase activity is required for megakaryocytic differentiation

J. Pérez-Simón, C. Trigueros, J. L. Sardina, 2010, Cell Death and Differentiation.

Bone marrow mesenchymal stem cells chimerism after allogeneic hematopoietic transplantation.

J. S. San Miguel, J. Pérez-Simón, C. del Cañizo, 2006, Experimental hematology.

Phase II trial of allogeneic transplantation plus novel drugs in multiple myeloma: effect of intensifying reduced intensity conditioning with bortezomib and adding maintenance treatment.

H. Einsele, R. Fanin, G. Gahrton, 2022, Transplantation and cellular therapy.

Panobinostat induces CD38 upregulation and augments the antimyeloma efficacy of daratumumab.

H. Einsele, J. Pérez-Simón, M. Hudecek, 2017, Blood.

Allocation to Matched Related or Unrelated Donor Results in Similar Clinical Outcomes without Increased Risk of Failure to Proceed to Transplant among Patients with Acute Myeloid Leukemia: A Retrospective Analysis from the Time of Transplant Approval.

J. Pérez-Simón, T. Caballero-Velázquez, E. Carreras, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Correction to: A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

J. Esteve, P. Martínez, M. Sanz, 2018, Annals of Hematology.

A phase I–II study of plerixafor in combination with fludarabine, idarubicin, cytarabine, and G-CSF (PLERIFLAG regimen) for the treatment of patients with the first early-relapsed or refractory acute myeloid leukemia

J. Esteve, P. Martínez, M. Sanz, 2018, Annals of Hematology.

Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease.

J. Sierra, S. Brunet, J. Pérez-Simón, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Immunomodulatory effect of mesenchymal stem cells.

C. Herrero, J. Pérez-Simón, 2010, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

Effect of vitamin D treatment in chronic GVHD

F. Sánchez-Guijo, J. Pérez-Simón, J. Miguel, 2011, Bone Marrow Transplantation.

Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib

J. Rodriguez-Barbosa, J. Pérez-Simón, C. García-Calderón, 2022, Scientific reports.

Combined treatment of graft versus host disease using donor regulatory T cells and ruxolitinib

J. Rodriguez-Barbosa, J. Pérez-Simón, C. García-Calderón, 2021, Scientific Reports.

Influence of the different CD34+ and CD34– cell subsets infused on clinical outcome after non‐myeloablative allogeneic peripheral blood transplantation from human leucocyte antigen‐identical sibling donors

Marcos González, A. Órfão, J. Pérez-Simón, 2002, British journal of haematology.

HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT

P. Schneider, J. Rodriguez-Barbosa, J. Pérez-Simón, 2019, Cellular & Molecular Immunology.

Relapse to prior autograft and chronic graft-versus-host disease are the strongest prognostic factors for outcome of melphalan/fludarabine-based dose-reduced allogeneic stem cell transplantation in patients with multiple myeloma.

N. Kröger, A. Zander, R. Brand, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Uptake and delivery of antigens by mesenchymal stromal cells.

F. Sánchez-Guijo, S. Muntión, C. Herrero, 2013, Cytotherapy.

Nonmyeloablative transplantation with or without alemtuzumab: comparison between 2 prospective studies in patients with lymphoproliferative disorders.

J. Garcia-conde, C. Craddock, S. Mackinnon, 2002, Blood.

ATRA works synergistically with the γ-secretase inhibitor crenigacestat to augment BCMA on multiple myeloma and the efficacy of BCMA-CAR T-cells.

H. Einsele, J. Pérez-Simón, M. Hudecek, 2022, Haematologica.

Acute leukemia arising from myeloproliferative or myelodysplastic/myeloproliferative neoplasms: A series of 372 patients from the PETHEMA AML registry.

M. Tormo, J. Pérez-Simón, Arturo Pereira, 2022, Leukemia research.

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving graft versus host disease prophylaxis with tacrolimus plus methotrexate or sirolimus

J. Miguel, J. González-Porras, F. Sánchez-Guijo, 2016 .

Risk factors for thrombotic microangiopathy in allogeneic hematopoietic stem cell recipients receiving GVHD prophylaxis with tacrolimus plus MTX or sirolimus

J. González-Porras, F. Sánchez-Guijo, J. Pérez-Simón, 2014, Bone Marrow Transplantation.

Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma.

E. Ocio, J. S. San Miguel, J. Pérez-Simón, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Deletion of chromosome band 13q14 as detected by fluorescence in situ hybridization is a prognostic factor in patients with multiple myeloma who are receiving allogeneic dose-reduced stem cell transplantation.

H. Einsele, N. Kröger, A. Zander, 2004, Blood.

Efficacy of bortezomib to intensify the conditioning regimen and the graft-versus-host disease prophylaxis for high-risk myeloma patients undergoing transplantation

N. Puig, J. S. San Miguel, J. Pérez-Simón, 2019, Bone Marrow Transplantation.

Human acute myeloid leukemia cells express Neurokinin-1 receptor, which is involved in the antileukemic effect of Neurokinin-1 receptor antagonists

J. Pérez-Simón, M. Muñoz, J. I. Piruat, 2019, Investigational New Drugs.

GvHD prophylaxis with tacrolimus plus sirolimus after reduced intensity conditioning allogeneic transplantation: results of a multicenter study

C. Solano, F. Sánchez-Guijo, J. Pérez-Simón, 2016, Bone Marrow Transplantation.

The combination of sirolimus plus tacrolimus improves outcome after reduced-intensity conditioning, unrelated donor hematopoietic stem cell transplantation compared with cyclosporine plus mycofenolate

C. Solano, J. Pérez-Simón, R. Martino, 2013, Haematologica.

Intermediate doses of cytarabine plus granulocyte–colony‐stimulating factor as an effective and safe regimen for hematopoietic stem cell collection in lymphoma patients with prior mobilization failure

J. Pérez-Simón, I. Espigado, J. Falantes, 2015, Transfusion.

Neurological Complications after Autologous Stem Cell Transplantation

N. Gutiérrez, J. S. San Miguel, Á. Guerrero, 1999, European Neurology.

Integrated flow cytometry and sequencing to reconstruct evolutionary patterns from dysplasia to acute myeloid leukemia

F. Prósper, M. Calasanz, M. Sanz, 2022, Blood advances.

Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients

F. Fernández‐Avilés, J. S. San Miguel, S. Brunet, 2006, Leukemia.

Use of bortezomib in the management of chronic graft-versus-host disease among multiple myeloma patients relapsing after allogeneic transplantation

J. S. San Miguel, J. Pérez-Simón, O. López, 2007, Haematologica.

Nº Gender Treatment Response GvHD Previous Immunosupression GvHD Follow-up and age

J. Pérez-Simón, 2007 .

Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation

F. Sánchez-Guijo, S. Muntión, J. S. San Miguel, 2012 .

IMiDs mobilize acute myeloid leukemia blasts to peripheral blood through downregulation of CXCR4 but fail to potentiate AraC/Idarubicin activity in preclinical models of non del5q/5q- AML

S. Menéndez, F. Gutiérrez-Agüera, J. Pérez-Simón, 2018, Oncoimmunology.

Impact of measurable residual disease by decentralized flow cytometry: a PETHEMA real-world study in 1076 patients with acute myeloid leukemia

E. Colado, M. González-Díaz, A. Órfão, 2021, Leukemia.

Human Bone Marrow Stromal Cells Differentiate into Corneal Tissue and Prevent Ocular Graft-Versus-Host Disease in Mice

J. Miguel, S. Carrancio, C. Herrero, 2015, Cell transplantation.

Incidence, characteristics and risk factors of marked hyperbilirubinemia after allogeneic hematopoietic cell transplantation with reduced-intensity conditioning

J. Pérez-Simón, R. Martino, I. Campos-Varela, 2012, Bone Marrow Transplantation.

Impact of Sars-CoV2 Infection on 491 Hematological Patients: The Ecovidehe Multicenter Study

C. Solano, E. Ocio, J. Pérez-Simón, 2020, Blood.

Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial

M. Kersten, P. Riedell, R. Malladi, 2021, Nature Medicine.

RIPK1 is a critical modulator of both tonic and TLR-responsive inflammatory and cell death pathways in human macrophage differentiation

J. Pérez-Simón, M. D. Moore, W. James, 2018, Cell Death & Disease.

First-in-Human Phase I Study of Iadademstat (ORY-1001): A First-in-Class Lysine-Specific Histone Demethylase 1A Inhibitor, in Relapsed or Refractory Acute Myeloid Leukemia

F. Bosch, C. Buesa, T. Somervaille, 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Sensitivity of hematopoietic stem cells to mitochondrial dysfunction by SdhD gene deletion

J. Pérez-Simón, I. V. Rosado, J. I. Piruat, 2016, Cell Death & Disease.

Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post‐allogeneic transplantation for high‐risk myeloma patients

J. S. San Miguel, J. Pérez-Simón, R. Martino, 2013, British journal of haematology.

Impact of genetic abnormalities on survival after allogeneic hematopoietic stem cell transplantation in multiple myeloma

J. San Miguel, J. Miguel, C. Bokemeyer, 2008, Leukemia.

Upregulation of CD38 expression on multiple myeloma cells by novel HDAC6 inhibitors is a class effect and augments the efficacy of daratumumab

H. Einsele, M. Sauer, J. Pérez-Simón, 2020, Leukemia.

Both expanded and uncultured mesenchymal stem cells from MDS patients are genomically abnormal, showing a specific genetic profile for the 5q− syndrome

J. Hernández-Rivas, J. García, F. Sánchez-Guijo, 2009, Leukemia.

Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool

J. Madrenas, J. Pérez-Simón, P. Menéndez, 2008, Journal of cellular and molecular medicine.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Tao Wang, Thomas Spitzer, Daniel J Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

In Vitro Simulation of Corneal Epithelium Microenvironment Induces a Corneal Epithelial-like Cell Phenotype from Human Adipose Tissue Mesenchymal Stem Cells

J. Pérez-Simón, M. Calonge, A. Corell, 2013, Current eye research.

Networking for advanced molecular diagnosis in acute myeloid leukemia patients is possible: the PETHEMA NGS-AML project

M. Tormo, M. González-Díaz, M. Calasanz, 2020, Haematologica.

Evolving treatment patterns and outcomes in older patients (≥60 years) with AML: changing everything to change nothing?

M. Tormo, M. Sanz, J. Pérez-Simón, 2020, Leukemia.

Overexpression of GYS1, MIF, and MYC is associated with adverse outcome and poor response to azacitidine in myelodysplastic syndromes and acute myeloid leukemia.

J. Pérez-Simón, J. I. Piruat, Á. Urbano-Ispizua, 2015, Clinical lymphoma, myeloma & leukemia.

Clinical prognostic factors for survival and risk of progression to acute myeloid leukemia in patients with myelodysplastic syndromes with < 10% marrow blasts and non-unfavorable cytogenetic categories.

J. Pérez-Simón, C. Calderón, Jose F Falantes, 2013, Clinical lymphoma, myeloma & leukemia.

Autologous stem-cell transplantation in diffuse large B-cell non-Hodgkin's lymphoma not achieving complete response after induction chemotherapy: the GEL/TAMO experience.

A. López-Guillermo, A. F. Sevilla, J. Sierra, 2004, Annals of oncology : official journal of the European Society for Medical Oncology.

Long-term bone marrow culture data are the most powerful predictor of peripheral blood progenitor cell mobilization in healthy donors.

F. Sánchez-Guijo, J. S. San Miguel, M. D. del Cañizo, 2005, Haematologica.

Comparison between a lyse-and-then-wash method and a lyse-non-wash technique for the enumeration of CD34+ hematopoietic progenitor cells.

A. Órfão, J. S. San Miguel, J. Gratama, 1998, Cytometry.

Granulocyte colony-stimulating factor produces long-term changes in gene and microRNA expression profiles in CD34+ cells from healthy donors

M. Barbado, J. Pérez-Simón, J. I. Piruat, 2014, Haematologica.

To freeze or not to freeze peripheral blood stem cells prior to allogeneic transplantation from matched related donors

J. Pérez-Simón, C. Calderón, L. Lopez-Corral, 2013, European journal of haematology.

Intensive monitoring program for oral food intake in patients undergoing allogeneic hematopoietic cell transplantation: a cost-benefit analysis.

J. Pérez-Simón, M. V. Calvo, M. Alaguero, 2002, Nutrition.

NON-MYELOABLATIVE TRANSPLANTS WITH OR WITHOUT CAMPATH-1H: COMPARISON BETWEEN TWO PROSPECTIVE STUDIES IN PATIENTS WITH LYMPHOPROLIFERATIVE DISORDERS.

Dolores, J. Garcia-conde, C. Craddock, 2002 .

Helicobacter pylori infection and graft-versus-host disease.

J. Pérez-Simón, T. Caballero-Velázquez, L. Lopez-Corral, 2011, Biology of Blood and Marrow Transplantation.

Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft‐versus‐host disease after allogeneic transplantation

J. S. San Miguel, M. D. del Cañizo, S. Brunet, 2005, British journal of haematology.

GVHD prophylaxis with sirolimus-tacrolimus may overcome the deleterious effect on survival of HLA mismatch after reduced-intensity conditioning allo-SCT

C. Solano, J. Pérez-Simón, R. Martino, 2015, Bone Marrow Transplantation.

Treatment options for relapse after autograft in multiple myeloma – report from an EBMT educational meeting

N. Kröger, G. Gahrton, G. Cook, 2017, Leukemia & lymphoma.

Compassionate use of ruxolitinib in acute and chronic graft versus host disease refractory both to corticosteroids and extracorporeal photopheresis

J. Pérez-Simón, Mauricio Sarmiento Maldonado, Mauricio Ocqueteau Tachini, 2017, Experimental Hematology & Oncology.

Elderly age and prior autologous transplantation have a deleterious effect on survival following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning: results from the Spanish multicenter prospective trial

C. Solano, J. Besalduch, J. Pérez-Simón, 2004, Bone Marrow Transplantation.

Clinical and Prognostic Value of Discrepancies in Microsatellite DNA Regions Between Recipient and Donor in Human Leukocyte Antigen-Identical Allogeneic Transplantation Setting

Marcos González, C. Santamaria, J. S. San Miguel, 2008, Transplantation.

Mesenchymal Stromal Cells for Treating Steroid-Resistant Acute and Chronic Graft Versus Host Disease: A Multicenter Compassionate Use Experience

J. Pérez-Simón, R. Sánchez-Pernaute, I. Espigado, 2022, Stem cells translational medicine.

Overcoming Chimeric Antigen Receptor (CAR) Modified T-Cell Therapy Limitations in Multiple Myeloma

J. Pérez-Simón, Belén Sierro-Martínez, E. García‐Guerrero, 2020, Frontiers in Immunology.

Long-Term Outcomes After Autologous Versus Allogeneic Stem Cell Transplantation in Molecularly-Stratified Patients With Intermediate Cytogenetic Risk Acute Myeloid Leukemia: A PETHEMA Study.

M. Tormo, M. Sanz, J. Pérez-Simón, 2021, Transplantation and cellular therapy.

Intravascular lymphoma: look through the small vessels

J. Pérez-Simón, J. Borrero, M. T. Vargas, 2017, Annals of Hematology.

High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group.

A. F. Sevilla, J. Garcia-conde, J. Sierra, 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

Impact of FLT3–ITD Mutation Status and Its Ratio in a Cohort of 2901 Patients Undergoing Upfront Intensive Chemotherapy: A PETHEMA Registry Study

M. Tormo, M. Calasanz, E. Barragán, 2022, Cancers.

Clinical benefit of glasdegib plus low-dose cytarabine in patients with de novo and secondary acute myeloid leukemia: long-term analysis of a phase II randomized trial

B. Leber, M. Heuser, J. Cortes, 2019, Annals of Hematology.

The effect of in vivo T cell depletion with alemtuzumab on reduced-intensity allogeneic hematopoietic cell transplantation for chronic lymphocytic leukemia.

J. Delgado, J. Sierra, R. Benjamin, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

LIGHT/HVEM/LTβR Interaction as a Target for the Modulation of the Allogeneic Immune Response in Transplantation

P. Schneider, J. Rodriguez-Barbosa, J. Pérez-Simón, 2013, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

Influence of glutathione S-transferase T1 donor/recipient mismatch and anti-GSTT1 antibodies in hepatic graft-versus-host-disease.

J. Pérez-Simón, I. Espigado, I. Aguilera, 2011, Immunology letters.

Gene and miRNA expression profiles of hematopoietic progenitor cells vary depending on their origin.

M. Barbado, J. Pérez-Simón, J. I. Piruat, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Role of 18F‐FDG‐PET/CT in the management of Burkitt lymphoma

J. Pérez-Simón, V. Marín-Oyaga, F. Capote, 2015, European journal of haematology.

The CD27+ memory B cells display changes in the gene expression pattern in elderly individuals

M. Barbado, J. Pérez-Simón, J. I. Piruat, 2015, Immunology.

Fludarabine/Busulfan versus Fludarabine/Melphalan Conditioning in Patients Undergoing Reduced-Intensity Conditioning Hematopoietic Stem Cell Transplantation for Lymphoma.

M. Terol, C. Solano, P. Armand, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Evaluation of a method for murine monocyte isolation by bone marrow depletion.

J. Pérez-Simón, J. L. Venero, Alejandro Carrillo-Jiménez, 2015, Analytical biochemistry.

A phase II, prospective, randomized, open-label study of defibrotide added to standard-of-care prophylaxis for the prevention of acute graft-versus-host disease after allogeneic hematopoietic cell transplantation

I. Yakoub-Agha, J. Pérez-Simón, D. Nachbaur, 2022, Haematologica.

HVEM, a cosignaling molecular switch, and its interactions with BTLA, CD160 and LIGHT

P. Schneider, J. Rodriguez-Barbosa, J. Pérez-Simón, 2019, Cellular & Molecular Immunology.

Depletion of alloreactive T-cells in vitro using the proteasome inhibitor bortezomib preserves the immune response against pathogens.

B. Blanco, C. Santamaria, J. Pérez-Simón, 2011, Leukemia research.

Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia (CLL) with 17p Deletion: A Retrospective EBMT Analysis.

N. Schmitz, A. Ganser, R. Brand, 2007 .

Combined vaccination with idiotype-pulsed allogeneic dendritic cells and soluble protein idiotype for multiple myeloma patients relapsing after reduced-intensity conditioning allogeneic stem cell transplantation

J. Miguel, A. Órfão, J. Pérez-Simón, 2006, Leukemia & lymphoma.

Reduced-intensity conditioning allogeneic transplantation from unrelated donors: evaluation of mycophenolate mofetil plus cyclosporin A as graft-versus-host disease prophylaxis.

J. S. San Miguel, J. Pérez-Simón, R. Martino, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Remarkable activity of novel agents bortezomib and thalidomide in patients not responding to donor lymphocyte infusions following nonmyeloablative allogeneic stem cell transplantation in multiple myeloma.

H. Goldschmidt, N. Kröger, A. Nagler, 2006, Blood.

LAG3 genotype of the donor and clinical outcome after allogeneic transplantation from HLA-identical sibling donors

I. Buño, E. Tuset, J. Pérez-Simón, 2023, Frontiers in Immunology.

First‐in‐human study of JNJ‐63709178, a CD123/CD3 targeting antibody, in relapsed/refractory acute myeloid leukemia

Xiang Li, J. Goldberg, M. Grunwald, 2022, Clinical and translational science.

Vincristine is an effective therapeutic approach for transplantation-associated thrombotic microangiopathy

J. Pérez-Simón, C. Cañizo, J. F. Miguel, 2006, Bone Marrow Transplantation.

Mismatch on glutathione S-transferase T1 increases the risk of graft-versus-host disease and mortality after allogeneic stem cell transplantation.

J. Pérez-Simón, I. Aguilera, M. Martínez-Bravo, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Effect of In Vivo T-Cell Depletion with Alemtuzumab on Reduced-Intensity Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia.

J. Delgado, J. Miguel, J. Sierra, 2007 .

Impact of Measurable Residual Disease (MRD) By Multiparameter Flow Cytometry (MFC): A Real-World Study in 1,076 Patients with Acute Myeloid Leukemia (AML)

E. Colado, Marcos González, A. Órfão, 2020 .

Functional expression of MDR-1 in acute myeloid leukemia: correlation with the clinical-biological, immunophenotypical, and prognostic disease characteristics

J. Miguel, A. Órfão, J. Pérez-Simón, 1997, Annals of Hematology.

European Myeloma Network: the 3rd Trialist Forum Consensus Statement from the European experts meeting on multiple myeloma

G. Morgan, H. Einsele, P. Sonneveld, 2010, Leukemia & lymphoma.

Results from a Pilot Study of ARI0002h, an Academic BCMA-Directed CAR-T Cell Therapy with Fractionated Initial Infusion and Booster Dose in Patients with Relapsed and/or Refractory Multiple Myeloma

F. Prósper, M. Juan, B. Paiva, 2021, Blood.

Prognostic Value of Measurable Residual Disease in Patients with AML Undergoing HSCT: A Multicenter Study

J. Pérez-Simón, M. Vidriales, T. Caballero-Velázquez, 2023, Cancers.

Combination of the Hematopoietic Cell Transplantation Comorbidity Index and the European Group for Blood and Marrow Transplantation score allows a better stratification of high-risk patients undergoing reduced-toxicity allogeneic hematopoietic cell transplantation.

F. Bosch, J. Sierra, J. Pérez-Simón, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Quality of life assessment in patients undergoing reduced intensity conditioning allogeneic as compared to autologous transplantation: results of a prospective study

J. Pérez-Simón, E. Ocio, J. Miguel, 2004, Bone Marrow Transplantation.

Comparison of outcomes for HLA-matched sibling and haplo-identical donors in Myelodysplastic syndromes: report from the chronic malignancies working party of EBMT

M. Robin, P. Chevallier, I. Yakoub-Agha, 2022, Blood Cancer Journal.

Complete cytogenetic but not molecular remission in a patient with myeloid blast crisis of chronic myeloid leukemia treated with carboplatin and ara-C.

J. S. San Miguel, J. Pérez-Simón, C. Chillón, 1997, Haematologica.

Conditioning‐based outcomes after allogeneic transplantation for myeloma following a prior autologous transplant (1991‐2012) on behalf of EBMT CMWP

N. Kröger, S. Iacobelli, I. Yakoub-Agha, 2019, European journal of haematology.

Strong periodic acid‐schiff reaction in hypervacuolated blastic plasmacytoid dendritic cell neoplasm

J. Pérez-Simón, T. Caballero-Velázquez, C. Prats-Martín, 2016, Diagnostic cytopathology.

Reply to A. Gratwohl

H. Einsele, J. Miguel, N. Kröger, 2011 .

De novo recipient-specific Glutathione S-transferase T1 antibody development after HLA-identical hematopoietic cell transplantation.

J. Pérez-Simón, M. J. Acevedo, I. Aguilera, 2017, Transplant immunology.

Molecular Landscape and Validation of New Genomic Classification in 2668 Adult AML Patients: Real Life Data from the PETHEMA Registry

M. Tormo, M. Calasanz, E. Barragán, 2023, Cancers.

Candida parapsilosis misleading the automated absolute and differential white blood cell count

J. Pérez-Simón, Maite Ruíz, C. Prats-Martín, 2016, Annals of Hematology.

Role of Hospital Exemption in Europe: position paper from the Spanish Advanced Therapy Network (TERAV).

M. Juan, L. Badimón, A. Zapata, 2023, Bone marrow transplantation.

Efficacy and Safety of Tisagenlecleucel in Adult Patients with Relapsed/Refractory Follicular Lymphoma: Interim Analysis of the Phase 2 Elara Trial

M. Kersten, P. Riedell, R. Malladi, 2020, Transplantation and Cellular Therapy.

Efficacy of Tisagenlecleucel in Adult Patients (Pts) with High-Risk Relapsed/Refractory Follicular Lymphoma (r/r FL): Subgroup Analysis of the Phase II Elara Study

M. Kersten, P. Riedell, R. Malladi, 2021, Blood.

Pre-transplant diastolic but not systolic dysfunction has a negative prognostic impact after allogeneic stem cell transplantation

J. Pérez-Simón, C. Calderón, I. Espigado, 2016, Bone Marrow Transplantation.

Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells

S. Scheu, P. Schneider, K. Pfeffer, 2016, mAbs.

Immune status of high-risk smoldering multiple myeloma patients and its therapeutic modulation under LenDex: a longitudinal analysis.

F. Prósper, N. Puig, A. Oriol, 2016, Blood.

Differential cytogenetic profile in advanced chronic myeloid leukemia with sequential lymphoblastic and myeloblastic blast crisis☆

J. Pérez-Simón, T. Caballero-Velázquez, R. Bernal, 2013, Leukemia research reports.

Chronic Graft-Versus-Host Disease

J. S. San Miguel, J. Pérez-Simón, M. Díez-Campelo, 2012, Drugs.

Long-Term Clinical Outcomes and Correlative Efficacy Analyses in Patients (Pts) with Relapsed/Refractory Follicular Lymphoma (r/r FL) Treated with Tisagenlecleucel in the Elara Trial

M. Kersten, P. Riedell, R. Malladi, 2022, Blood.

Genetic deletion of HVEM in a leukemia B cell line promotes a preferential increase of PD-1- stem cell-like T cells over PD-1+ T cells curbing tumor progression

J. Rodriguez-Barbosa, J. Pérez-Simón, M. Del Río, 2023, Frontiers in Immunology.

Caspase-8 inhibition represses initial human monocyte activation in septic shock model

B. Joseph, J. Pérez-Simón, J. Rodhe, 2016, Oncotarget.

Multivariable time-dependent analysis of the impact of azacitidine in patients with lower-risk myelodysplastic syndrome and unfavorable specific lower-risk score.

M. Tormo, J. González-Porras, S. Brunet, 2015, Leukemia research.

Influence of the Intensity of the Conditioning Regimen on the Characteristics of Acute and Chronic Graft Versus Host Disease after Allogeneic Transplantation.

J. Miguel, J. Sierra, S. Brunet, 2004 .

Long-Term Impact of an Educational Antimicrobial Stewardship Program on Management of Patients with Hematological Diseases

J. Pérez-Simón, J. Lepe, J. Cisneros, 2021, Antibiotics.

Comparison of the 2022 and 2017 European LeukemiaNet risk classifications in a real-life cohort of the PETHEMA group

M. Tormo, M. Calasanz, E. Barragán, 2023, Blood Cancer Journal.

Lenograstim compared to filgrastim for the mobilization of hematopoietic stem cells in healthy donors

J. Pérez-Simón, J. Martín-Sánchez, R. Parody-Porras, 2013, Transfusion.

A precision medicine test predicts clinical response after idarubicin and cytarabine induction therapy in AML patients.

M. Tormo, M. Sanz, P. Hernández-Campo, 2019, Leukemia research.

Evaluation of Parameters Related to the Probability of Leukemic Progression in Patients With Lower‐Risk Myelodysplastic Syndrome

J. Pérez-Simón, I. Espigado, J. Falantes, 2018, Clinical lymphoma, myeloma & leukemia.

Natural killer cell alloreactivity in HLA-haploidentical hematopoietic transplantation: a study on behalf of the CTIWP of the EBMT

A. Nagler, L. Ruggeri, A. Velardi, 2021, Bone Marrow Transplantation.

Cholinergic signals preserve haematopoietic stem cell quiescence during regenerative haematopoiesis

B. Göttgens, J. Pérez-Simón, S. Méndez-Ferrer, 2022, Nature communications.

Drug rash with eosinophilia and systemic symptoms (DRESS) after an unrelated donor BM transplant

J. Pérez-Simón, Á. Santos-Briz, L. Vázquez, 2011, Bone Marrow Transplantation.

Cannabinoid derivatives exert a potent anti‐myeloma activity both in vitro and in vivo

N. Campillo, M. Barbado, J. Pérez-Simón, 2017, International journal of cancer.

Monitoring of kinetics and exhaustion markers of circulating CAR-T cells as early predictive factors in patients with B-cell malignancies

J. Briones, J. Pérez-Simón, C. García-Calderón, 2023, Frontiers in Immunology.

The impact of CD160 deficiency on alloreactive CD8 T cell responses and allograft rejection.

A. Gutiérrez-Adán, J. Rodriguez-Barbosa, J. Pérez-Simón, 2021, Translational research : the journal of laboratory and clinical medicine.

Genotoxicity of tetrahydrofolic acid to hematopoietic stem and progenitor cells

J. Pérez-Simón, C. García-Calderón, I. V. Rosado, 2018, Cell Death & Differentiation.

Black bone marrow

J. Pérez-Simón, R. Bernal, C. Calderón‐Cabrera, 2015, Diagnostic cytopathology.

RIPK1 is a critical modulator of both tonic and TLR-responsive inflammatory and cell death pathways in human macrophage differentiation

J. Pérez-Simón, M. D. Moore, W. James, 2018, Cell Death & Disease.

Long‐term follow‐up in patients treated with Mini‐BEAM as salvage therapy for relapsed or refractory Hodgkin's disease

J. S. San Miguel, J. Pérez-Simón, F. Hernández-Navarro, 2001, British journal of haematology.

Fractionated initial infusion and booster dose of ARI0002h, a humanised, BCMA-directed CAR T-cell therapy, for patients with relapsed or refractory multiple myeloma (CARTBCMA-HCB-01): a single-arm, multicentre, academic pilot study.

M. Juan, B. Paiva, J. Pérez-Simón, 2023, The Lancet. Oncology.

Ruxolitinib in refractory acute and chronic graft-versus-host disease: a multicenter survey study

J. Sierra, J. Pérez-Simón, T. Caballero-Velázquez, 2019, Bone Marrow Transplantation.

Etoposide plus cytarabine versus cyclophosphamide or melphalan in busulfan-based preparative regimens for autologous stem cell transplantation in adults with acute myeloid leukemia in first complete remission: a study from the Acute Leukemia Working Party of the EBMT

M. Labopin, M. Mohty, F. Lanza, 2023, Bone Marrow Transplantation.

KIT D816V− chronic myelomonocytic leukemia progressing to KIT D816V+ associated to mast cell leukemia responding to allogeneic hematopoietic cell transplantation

J. Pérez-Simón, T. Caballero-Velázquez, J. Borrero, 2018, Annals of Hematology.

Immunomodulatory effect of 5-azacytidine (5-azaC): potential role in the transplantation setting.

F. J. Gonzalez, E. Ballestar, B. Blanco, 2010, Blood.

ECP versus ruxolitinib in steroid-refractory acute GVHD – a retrospective study by the EBMT transplant complications working party

J. Pérez-Simón, Z. Perić, Z. Ozkurt, 2023, Frontiers in Immunology.

Are myeloma patients with renal failure candidates for autologous stem cell transplantation?

C. Solano, J. Maldonado, J. S. San Miguel, 2000, The hematology journal : the official journal of the European Haematology Association.

The granulocyte colony-stimulating factor produces long-term changes on gene and miRNA expression profiles in CD34+ cells from healthy donors

J. Pérez-Simón, Á. Urbano-Ispizua, Beatriz, 2013 .

Pentostatin plus cyclophosphamide and bexarotene is an effective and safe combination in patients with mycosis fungoides/sezary syndrome

J. Pérez-Simón, A. Marín-Niebla, J. Falantes, 2013, British journal of haematology.

Mesenchymal stem cells are functionally abnormal in patients with immune thrombocytopenic purpura.

B. Blanco, J. S. San Miguel, J. Pérez-Simón, 2009, Cytotherapy.

Immunotherapeutic targeting of LIGHT/LTβR/HVEM pathway fully recapitulates the reduced cytotoxic phenotype of LIGHT-deficient T cells

S. Scheu, P. Schneider, K. Pfeffer, 2016, mAbs.

Clinical significance of CD34+ cell dose in long-term engraftment following autologous peripheral blood stem cell transplantation

A. Órfão, J. Pérez-Simón, M. González, 1999, Bone Marrow Transplantation.

Cannabinoids induce cell death in leukaemic cells through Parthanatos and PARP-related metabolic disruptions

J. Pérez-Simón, T. Caballero-Velázquez, M. Medrano, 2024, British Journal of Cancer.

Allogeneic mesenchymal stem cell therapy for refractory cytopenias after hematopoietic stem cell transplantation

S. Muntión, J. S. San Miguel, M. D. del Cañizo, 2012, Transfusion.

C. Solano, J. Pérez-Simón, R. Martino, 2013, Haematologica.

A prospective PETHEMA study of tandem autologous transplantation versus autograft followed by reduced-intensity conditioning allogeneic transplantation in newly diagnosed multiple myeloma.

J. S. San Miguel, J. Pérez-Simón, J. Bladé, 2008, Blood.

Pre-Clinical Trial to Evaluate the Efficacy of Delayed Administration of Ixazomib in the Prophylaxis of Chronic Graft-Versus-Host Disease

M. Barbado, J. Pérez-Simón, T. Caballero-Velázquez, 2018, Blood.

MUFAs in High-Fat Diets Protect against Obesity-Induced Bias of Haematopoietic Cell Lineages.

J. Pérez-Simón, M. Millán-Linares, R. Abia, 2021, Molecular nutrition & food research.

Chimerism analysis following allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning

J. Pérez-Simón, R. Martino, J. Bargay, 2003, Bone Marrow Transplantation.

Chimeric antigen receptor (CAR) modified T Cells in acute myeloid leukemia: limitations and expectations

J. Pérez-Simón, E. Rodríguez-Arbolí, Beatriz Guijarro-Albaladejo, 2024, Frontiers in cell and developmental biology.

Impact of disease burden and late loss of B cell aplasia on the risk of relapse after CD19 chimeric antigen receptor T Cell (Tisagenlecleucel) infusion in pediatric and young adult patients with relapse/refractory acute lymphoblastic leukemia: role of B-cell monitoring

J. Pérez-Simón, M. Torrebadell, T. Caballero-Velázquez, 2024, Frontiers in immunology.

Biomarker‑driven phase Ib clinical trial of OPB‑111077 in acute myeloid leukemia

J. Pérez-Simón, J. Gorrochategui, J. Martínez-López, 2022, Medicine international.

Post-transplant cyclophosphamide-based graft-versus-host disease prophylaxis in HLA-matched and haploidentical donor transplants for patients with Hodgkin lymphoma: a comparative study of the LWP EBMT.: GVHD prophylaxis for patients with Hodgkin lymphoma.

J. Pérez-Simón, L. Castagna, A. Dominietto, 2023, Transplantation and cellular therapy.

Anti-common γ-chain antibody: one for all in GVHD.

J. Pérez-Simón, 2015, Blood.

COVID-19 in patients with haematologic malignancies: effect of RNAemia on clinical outcome in vaccinated patients.

J. Pérez-Simón, J. Sánchez-Céspedes, J. Pachón, 2024, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

RUNX1 amplification in AML with myelodysplasia‐related changes and ring 21 chromosomes

J. Pérez-Simón, T. Caballero-Velázquez, J. García-Lozano, 2017, Hematological oncology.

Oral beclomethasone dipropionate for the treatment of gastrointestinal acute graft-versus-host disease (GVHD).

E. Ocio, F. Sánchez-Guijo, J. S. San Miguel, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

PTCy vs CNI–based GVHD prophylaxis in HLA-matched transplants for Hodgkin lymphoma: a study of the LWP of the EBMT

J. Pérez-Simón, I. Sakellari, P. Matteucci, 2024, Blood advances.

PTPN13 regulates cellular signalling and β-catenin function during megakaryocytic differentiation.

F. Antequera, J. Pérez-Simón, L. Quintales, 2014, Biochimica et biophysica acta.